Peptide record

TPDB43046

Anticancer Tumor T cell antigens standard
9 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB43046
Anticancer Tumor T cell antigens
Cancer-related peptides
dbACP ENCAP iTTCA-Hybrid iTTCA-RF LYnet-master
standard
No
A 9-aa standard-residue multi-activity (Anticancer and Tumor T cell antigens) peptide sequence curated from dbACP, ENCAP, iTTCA-Hybrid, and other sources, with an available 3D structural model.
Sequence
TFDYLRSVL
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C52H80N12O15
ANCEQGHIKMPW
L
1113.28
6.71
1
1
5
-0
1.43
0.422
118.89
Mammalian: 7.2 hour Yeast: >20 hour E.coli: >10 hour
1490
1.34
3
Residue Composition
number
0
A
1
R
0
N
1
D
0
C
0
E
0
Q
0
G
0
H
0
I
2
L
0
K
0
M
1
F
0
P
1
S
1
T
0
W
1
Y
1
V
Amino Acid Distribution
A: 0 R: 1 N: 0 D: 1 C: 0 E: 0 Q: 0 G: 0 H: 0 I: 0 L: 2 K: 0 M: 0 F: 1 P: 0 S: 1 T: 1 W: 0 Y: 1 V: 1
Chemical Descriptors
9 reviewed residue count
C52H80N12O15 sequence-only estimate (linear, free termini)
1113.28 sequence-only estimate (linear, free termini)
6.71 sequence-only estimate (linear, free termini)
-0 sequence-only estimate (linear, free termini)
1.43 sequence-only estimate (linear, free termini)
0.422 sequence-only estimate (linear, free termini)
Evidence Records 1 records
Evidence 1 Activity

Activity

Tumor T cell antigens

Assay & Model

in vitro

Source & Reference

NA
TANTIGEN/TADB

Other

T-cell epitope
A*2402
Unclassified
Unclassified
Additional Detail Fields 3 fields
Unclassified
Unclassified
A*2402